Literature DB >> 27210310

Successful therapy with tonsillectomy plus pulse therapy for the relapse of pediatric IgA nephropathy treated with multi-drugs combination therapy.

Nobuko Sakai1, Yukihiko Kawasaki, Tomoko Waragai, Tomoko Oikawa, Masatoshi Kaneko, Tomoko Sato, Kazuhide Suyama, Mitsuaki Hosoya.   

Abstract

Immunoglobulin A nephropathy (IgAN) is the most common form of chronic glomerulonephritis worldwide. In Japan, the treatment for use as an initial therapy was established in Guidelines for the Treatment of Childhood IgA nephropathy; however, no rescue therapy for recurrent or steroid-resistant pediatric IgAN was established. We report here a 15-year-old boy with severe IgAN, who was treated with combination therapy involving prednisolone, mizoribine, warfarin, and dilazep dihydrochloride for 2 years. The response to the combination therapy was good and both proteinuria and hematuria disappeared. The pathological findings at the second renal biopsy were improved and PSL was discontinued. However, due to nonadherence to the treatment regimen and tonsillitis, macrohematuria and an increase of proteinuria were again observed and the pathological findings at the third renal biopsy showed clear deterioration. The patient was, therefore, diagnosed with recurrent IgAN. Tonsillectomy plus methylprednisolone pulse therapy (TMP) was performed as a rescue therapy for the recurrence of severe IgAN. Both the proteinuria or hematuria subsequently disappeared, and no proteinuria or hematuria has been observed and kidney function has remained normal during a 5-year follow-up. The patient experienced no severe side effects associated with the drug regimens. In conclusion, our case suggests that TMP may be an effective and useful rescue therapy for recurrent IgAN after multi-drug combination therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27210310      PMCID: PMC5131584          DOI: 10.5387/fms.2016-3

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  17 in total

1.  Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.

Authors:  O Hotta; M Miyazaki; T Furuta; S Tomioka; S Chiba; I Horigome; K Abe; Y Taguma
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

2.  Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis.

Authors:  T R Welch; C Fryer; E Shely; D P Witte; M Quinlan
Journal:  J Pediatr       Date:  1992-09       Impact factor: 4.406

Review 3.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

4.  A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.

Authors:  N Yoshikawa; H Ito; T Sakai; Y Takekoshi; M Honda; M Awazu; K Ito; K Iitaka; Y Koitabashi; K Yamaoka; K Nakagawa; H Nakamura; S Matsuyama; Y Seino; N Takeda; S Hattori; M Ninomiya
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

5.  Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy.

Authors:  Yukihiko Kawasaki; Kei Takano; Kazuhide Suyama; Masato Isome; Hideki Suzuki; Hiroko Sakuma; Tomoo Fujiki; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

6.  Tonsillectomy for IgA nephropathy: a meta-analysis.

Authors:  Lin-lin Liu; Li-ning Wang; Yi Jiang; Li Yao; Li-ping Dong; Zi-long Li; Xiao-li Li
Journal:  Am J Kidney Dis       Date:  2014-10-22       Impact factor: 8.860

7.  A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy.

Authors:  You Wang; Junying Chen; Yan'e Wang; Yan Chen; Le Wang; Yongman Lv
Journal:  Nephrol Dial Transplant       Date:  2010-11-16       Impact factor: 5.992

8.  Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy.

Authors:  Yukihiko Kawasaki; Junzo Suzuki; Nobuko Sakai; Shigehiko Etoh; Hiromitch Murai; Ruriko Nozawa; Hitoshi Suzuki
Journal:  Am J Nephrol       Date:  2004-01-14       Impact factor: 3.754

9.  Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Kyohei Miyazaki; Shuto Kanno; Atsushi Ono; Yuichi Suzuki; Masatoki Sato; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Nephrology (Carlton)       Date:  2014-07       Impact factor: 2.506

10.  Improved renal survival in Japanese children with IgA nephropathy.

Authors:  Nahoko Yata; Koichi Nakanishi; Yuko Shima; Hiroko Togawa; Mina Obana; Mayumi Sako; Kandai Nozu; Ryojiro Tanaka; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.